{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:11:49Z","timestamp":1778854309321,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45590-2","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:50:15Z","timestamp":1774673415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The oncogenic effect and mechanism of LINC00520\/miR-372\/SLC7A11 axis in renal clear cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yong-Bo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-You","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-tian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"45590_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay, J. et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur. J. Cancer 103, 356\u2013387 (2018).","journal-title":"Eur. J. Cancer"},{"key":"45590_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/21681805.2013.864698","volume":"48","author":"A Thorstenson","year":"2014","unstructured":"Thorstenson, A. et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005\u20132010: A population-based study from the national Swedish kidney cancer register. Scand J. Urol. 48, 231\u2013238 (2014).","journal-title":"Scand J. Urol."},{"key":"45590_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E. & Ulbright, T. M. The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part A: Renal, penile, and testicular tumours. Eur. Urol. 70, 93\u2013105 (2016).","journal-title":"Eur. Urol."},{"key":"45590_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A. & Bray, F. International variations and trends in renal cell carcinoma incidence and mortality. Eur. Urol. 67, 519\u2013530 (2015).","journal-title":"Eur. Urol."},{"issue":"4","key":"45590_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"J Bedke","year":"2022","unstructured":"Bedke, J. et al. European association of urology guidelines on renal cell carcinoma: The 2022 update. Eur. Urol. 82(4), 399\u2013410 (2022).","journal-title":"Eur. Urol."},{"issue":"3","key":"45590_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language?. Cell 146(3), 353\u2013358 (2011).","journal-title":"Cell"},{"issue":"7209","key":"45590_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209), 58\u201363 (2008).","journal-title":"Nature"},{"issue":"10","key":"45590_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Qi, X. et al. ceRNA in cancer: possible functions and clinical implications. J. Med. Genet. 52(10), 710\u2013718 (2015).","journal-title":"J. Med. Genet."},{"issue":"5","key":"45590_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W. & Dinger, M. E. Endogenous microRNA sponges: Evidence and controversy. Nat. Rev. Genet. 17(5), 272\u2013283 (2016).","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"45590_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms19051310","volume":"19","author":"JJ Chan","year":"2018","unstructured":"Chan, J. J. & Tay, Y. Noncoding RNA:RNA regulatory networks in cancer. Int. J. Mol. Sci. 19(5), 1310 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"45590_CR11","doi-asserted-by":"publisher","first-page":"5589101","DOI":"10.1155\/2021\/5589101","volume":"2021","author":"YB Chen","year":"2021","unstructured":"Chen, Y. B. et al. Weighted gene coexpression network analysis to construct competitive endogenous RNA network in chromogenic renal cell carcinoma. Biomed. Res. Int. 2021, 5589101 (2021).","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"45590_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbrc.2013.04.074","volume":"435","author":"W He","year":"2013","unstructured":"He, W. et al. Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression. Biochem. Biophys. Res. Commun. 435(4), 526\u2013532 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"45590_CR13","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1158\/1078-0432.CCR-10-1461","volume":"16","author":"G Chang","year":"2010","unstructured":"Chang, G. et al. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin. Cancer Res. 16(22), 5390\u20135401 (2010).","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"45590_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mc.20535","volume":"48","author":"NA Cody","year":"2009","unstructured":"Cody, N. A. et al. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer. Mol. Carcinog. 48(12), 1077\u20131092 (2009).","journal-title":"Mol. Carcinog."},{"issue":"10","key":"45590_CR15","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1167\/iovs.09-5083","volume":"51","author":"SL Lake","year":"2010","unstructured":"Lake, S. L., Coupland, S. E., Taktak, A. F. & Damato, B. E. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest. Ophthalmol. Vis. Sci. 51(10), 4884\u20134891 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"45590_CR16","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1182\/blood-2010-12-323659","volume":"118","author":"D Roy","year":"2011","unstructured":"Roy, D., Sin, S. H., Damania, B. & Dittmer, D. P. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood 118(7), e32\u2013e39 (2011).","journal-title":"Blood"},{"issue":"3","key":"45590_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s13577-020-00336-8","volume":"33","author":"XH Jin","year":"2020","unstructured":"Jin, X. H., Hong, Y. G., Li, P., Hao, L. Q. & Chen, M. Long noncoding RNA LINC00520 accelerates the progression of colorectal cancer by serving as a competing endogenous RNA of microRNA-577 to increase HSP27 expression. Hum. Cell 33(3), 683\u2013694 (2020).","journal-title":"Hum. Cell"},{"issue":"1","key":"45590_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula, P., Zhang, Y., Zhuang, L. & Gan, B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun. (Lond.) 38(1), 12 (2018).","journal-title":"Cancer Commun. (Lond.)"},{"issue":"1","key":"45590_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49136-8","volume":"13","author":"M Lei","year":"2023","unstructured":"Lei, M. et al. Gankyrin inhibits ferroptosis through the p53\/SLC7A11\/GPX4 axis in triple-negative breast cancer cells. Sci. Rep. 13(1), 21916 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"45590_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-017-0681-0","volume":"16","author":"JK Li","year":"2017","unstructured":"Li, J. K. et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol. Cancer. 16(1), 111 (2017).","journal-title":"Mol. Cancer."},{"issue":"15","key":"45590_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158284","volume":"25","author":"J Yue","year":"2024","unstructured":"Yue, J. et al. Discovery of the inhibitor targeting the SLC7A11\/xCT axis through in silico and in vitro experiments. Int. J. Mol. Sci. 25(15), 8284 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"45590_CR22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.febslet.2012.03.053","volume":"586","author":"XX Liu","year":"2012","unstructured":"Liu, X. X. et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 586(9), 1356\u20131362 (2012).","journal-title":"FEBS Lett."},{"issue":"10","key":"45590_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2217\/fon-2017-0540","volume":"14","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Overexpression of SLC7A11: A novel oncogene and an indicator of unfavorable prognosis for liver carcinoma. Future Oncol. 14(10), 927\u2013936 (2018).","journal-title":"Future Oncol."},{"issue":"36","key":"45590_CR24","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","volume":"37","author":"X Ji","year":"2018","unstructured":"Ji, X. et al. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 37(36), 5007\u20135019 (2018).","journal-title":"Oncogene"},{"issue":"5","key":"45590_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/cpr.12207","volume":"48","author":"X Huang","year":"2015","unstructured":"Huang, X., Huang, M., Kong, L. & Li, Y. miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma. Cell Prolif. 48(5), 593\u2013599 (2015).","journal-title":"Cell Prolif."},{"key":"45590_CR26","unstructured":"Shi, Q. J., Su, X. L., Zhang, H. J., Han, Z. X., Zhao, Y. Q., & Liu, Q. J. MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma. Oncology Letters, 17(3), 2400\u20132408 (2019)."},{"key":"45590_CR27","doi-asserted-by":"crossref","unstructured":"Zhang, L., et al. miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. BMC Cancer. 14(1), 107 (2014).","DOI":"10.1186\/1471-2407-14-107"},{"issue":"4","key":"45590_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","volume":"20","author":"A Hafner","year":"2019","unstructured":"Hafner, A., Bulyk, M. L., Jambhekar, A. & Lahav, G. The multiple mechanisms that regulate p53 activity and cell fate. Nat. Rev. Mol. Cell Biol. 20(4), 199\u2013210 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45590-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:53:01Z","timestamp":1778853181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45590-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45590-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"15191"}}